Clinical Trial Update: Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting

View source ↗

Summary

The trial update reports that inflammatory biomarkers may predict pulmonary outcomes in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Coronary Artery Disease

Snippet

Sponsor: Emory University | Conditions: Coronary Artery Disease, Chronic Obstructive Pulmonary Disease | Status: COMPLETED